Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

Pradaxa, Xarelto and apixaban vie for attention

September 6, 2010 Research and Development, Sales and Marketing Pradaxa, Xarelto, apixaban, atrial fibrilation

New data has intensified the competition between three rival would-be cardiology blockbusters. Boehringer Ingelheim’s Pradaxa (dabigatran) and Bayer’s Xarelto (rivaroxaban) …
News
Roche building

Roche set for jobs cuts from 2011

September 3, 2010 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Roche, job cuts

Roche has confirmed it will take wide-ranging steps to reduce costs, following local reports the Swiss pharma firm was poised …
News

UK biotech body elects new chairman

September 3, 2010 Research and Development BIA, appointment, research and development

Cellzome’s president and chief executive Tim Edwards has been elected chairman of the BioIndustry Association. Commenting on his election he …
Appointment

Contract research news in brief

September 3, 2010 Research and Development Cyprotex, Epistem, INC Research, Jubilant, Laxal Pharma

A round-up of recent news from the CRO sector, featuring updates from Cyprotex, INC Research, Laxai Pharma, Asuragen, Jubilant Organosys …
News
Nigel Brooksby

Nigel Brooksby joins Prism Ideas

September 2, 2010 Medical Communications, Research and Development Prism Ideas, appointment, medical communications, research and development

Former Sanofi-Aventis UK chairman and managing director Nigel Brooksby has joined Cheshire, UK-based Prism Ideas as non-executive chairman. The medical …
Appointment

Genzyme available for ‘fair value’, says Termeer

September 2, 2010 Research and Development, Sales and Marketing Genzyme, Sanofi-Aventis

Genzyme’s chief executive Henri Termeer has said his company could be for sale to Sanofi-Aventis if it offers a ‘fair …
News

Pfizer acquires ‘protein misfolding’ specialist

September 2, 2010 Research and Development FoldRx, Pfizer, cystic fibrosis

Pfizer has bolstered its presence in rare and orphan diseases with the acquisition of FoldRx, a US drug discovery firm …
News

Cephalon chairman takes leave of absence

September 2, 2010 Research and Development, Sales and Marketing Cephalon, appointment, research and development, sales and marketing

Cephalon’s chairman and chief executive Frank Baldino Jr is taking a medical leave of absence with immediate effect. The company …
Appointment

Lung cancer vaccine poised to begin phase IIb/III trials

September 1, 2010 Research and Development NSCLC, TG4010, Transgene, cancer vaccine

French biotech firm Transgene has received positive scientific advice from the EMA for late stage trials of its new lung …
News

Eye treatment could be commercial breakthrough for ThromboGenics

September 1, 2010 Research and Development ThromboGenics, eye care, microplasmin

Belgian biopharma company ThromboGenics could have a major product on its hands in the shape of new eye treatment. The …
News
Pandemrix pack

EMA to assess GSK flu vaccine for narcolepsy link

September 1, 2010 Research and Development, Sales and Marketing GlaxoSmithKline, Pandemrix, h1n1

The European Medicines Agency has launched a review of GlaxoSmithKline’s influenza vaccine Pandemrix. The European Commission asked the EMA to …
News

Pharma and the iPhone: there’s an app for that

September 1, 2010 Medical Communications, Research and Development, Sales and Marketing ipad, iphone

The iPhone and its new, larger cousin the iPad, have captured the hearts of many technology lovers, and have ushered …
Feature

Talking R&D: Strategic vs full service CRO

September 1, 2010 Research and Development CRO, Talking Point, Talking R&D

CRF Health’s Greg Jewett and Medpace’s Alita Hassan debate the merits of a strategic or a full service contract research …
Feature
Roche building

Roche coy on job cut reports

September 1, 2010 Manufacturing and Production, Research and Development, Sales and Marketing Roche, job cuts

Roche is reportedly set to cut thousands of pharma jobs to reduce costs and boost profitability following a series of …
News

Kendle appoints Mark Roseman chief marketing officer

September 1, 2010 Research and Development Kendle, appointment, research and development

Mark Roseman has joined clinical research organisation Kendle as senior vice president and chief marketing officer. He has more than …
Appointment
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025